Identification of a Novel LAMP2 Mutation Responsible for X-Chromosomal Dominant Danon Disease

Abstract

Danon disease (DD) is a rare lysosomal glycogen storage disease with normal acid maltase activity, which is characterised clinically by cardiomyopathy and myopathy, and a variable degree of mental retardation. The causative gene, LAMP2, has been mapped to chromosome Xq24-q25. LAMP2 encodes a lysosome-associated membrane glycoprotein. We identified a novel LAMP2 mutation of the exon 8 splice acceptor site (IVS7-1G → A) in an affected male and female, which predicts abnormal splicing. Both affected individuals presented solely with hypertrophic cardiomyopathy. Muscle weakness and mental impairment were absent. Diagnosis of Danon disease was established by muscle biopsy, when the male index patient developed transient severe muscle weakness following heart transplantation. Typical biopsy findings were also found in a heart muscle specimen. Demonstration of the LAMP2 mutation in affected male and female siblings is compatible with X-linked dominant inheritance. Danon disease should be actively looked for in cardiomyopathy patients.

Danon disease - glycogen storage disease type IIb - LAMP2

References

• 1 Byrne E, Dennett X, Crotty B, Trounce I, Sands J M, Hawkins R. et al . Dominantly inherited cardioskeletal myopathy with lysosomal glycogen storage and normal acid maltase levels.  Brain. 1986;  109 523-536
• 2 Danon M J, Oh S J, DiMauro S, Manaligod J R, Eastwood A, Naidu S, Schliselfeld L H. Lysosomal glycogen storage disease with normal acid maltase.  Neurology. 1981;  31 51-57
• 3 Dworzak F, Casazza F, Mora M, De Maria R, Gronda E, Baroldi G. et al . Lysosomal glycogen storage with normal acid maltase: a familial study with successful heart transplant.  Neuromusc Disord. 1994;  4 243-247
• 4 Konecki D S, Foetisch K, Zimmer K P, Schlotter M, Lichter-Konecki U. An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner.  Biochem Biophys Res Commun. 1995;  215 757-767
• 5 Mattei M G, Matterson J, Chen J W, Williams M A, Fukuda M. Two human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2, are encoded by genes localized to chromosome 13 q34 and chromosome Xq24 - 25, respectively.  J Biol Chem. 1990;  265 7548-7551
• 6 Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T. et al . Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).  Nature. 2000;  406 906-910
• 7 Riggs J E, Schochet S S, Gutmann L, Shanske S, Neal W A, DiMauro S. Lysosomal glycogen storage disease without acid maltase deficiency.  Neurology. 1983;  33 873-877
• 8 Sugie K, Yamamoto A, Murayama K, Oh S J, Takahashi M, Mora M. et al . Clinicopathological features of genetically confirmed Danon disease.  Neurology. 2002;  58 1773-1778
• 9 Takahashi M, Yamamoto A, Takano K, Sudo A, Wada T, Goto Y. et al . Germline mosaicism of a novel mutation in lysosome-associated membrane protein-2 deficiency (Danon disease).  Ann Neur. 2002;  52 122-125
• 10 Tanaka Y, Guhde G, Suter A, Eskelinen E L, Hartmann D, Lullmann-Rauch R. et al . Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice.  Nature. 2000;  406 902-906